Picture of Daito Pharmaceutical logo

4577 — Daito Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeSmall CapSuper Stock

Table: Daito -Q1 group results

Oct 12 (Reuters)-  
             Daito Pharamaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Aug 31, 2016        Aug 31, 2015     May 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             9.11                8.73             38.10     
                 (+4.3 pct)          (+17.7 pct)      (+4.8 pct)   
  Operating        929 mln             968 mln            3.70     
                 (-4.0 pct)          (+35.0 pct)      (+4.1 pct)   
  Recurring        967 mln              1.01              3.75     
                 (-4.0 pct)          (+40.9 pct)      (+1.0 pct)   
  Net              671 mln             678 mln            2.60     
                 (-1.0 pct)          (+48.6 pct)      (+1.3 pct)   
  EPS             53.67 yen           54.23 yen       207.76 yen   
  Ann Div                             30.00 yen        30.00 yen   
  -Q2 div                             15.00 yen        15.00 yen   
  -Q4 div                             15.00 yen        15.00 yen   
   
  NOTE - Daito Pharamaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Daito Pharmaceutical

See all news